Probing the Release of Bupropion and Naltrexone Hydrochloride Salts from Biopolymeric Matrices of Diverse Chemical Structures
Autor: | Marilena Vlachou, Angeliki Siamidi, Aikaterini Dedeloudi |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Naltrexone Hydrochloride
Polymers and Plastics Organic chemistry biopolymers 02 engineering and technology bupropion 030226 pharmacology & pharmacy Naltrexone Article 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine QD241-441 ulvan medicine Dissolution modified release chemistry.chemical_classification Acrylate Ethylene oxide Chemistry General Chemistry Polymer 021001 nanoscience & nanotechnology Combinatorial chemistry Drug delivery matrix tablet Bupropion hydrochloride 0210 nano-technology naltrexone medicine.drug |
Zdroj: | Polymers Polymers, Vol 13, Iss 1456, p 1456 (2021) Volume 13 Issue 9 |
ISSN: | 2073-4360 |
Popis: | In the last decades, the notion of including excipients in the formulations, as inert substances aiding production processes, has changed and they are recently viewed as multifunctional discrete entities. It is now well documented that excipients serve several roles, spreading from the stabilization and modified release, to providing biocompatible properties and targeting moieties. The aim of this study was to develop matrix-based oral drug delivery systems of bupropion hydrochloride (BUP·HCl) and naltrexone hydrochloride (NTX·HCl), suitable for releasing these active substances in a modified manner, providing a stable level of drug release, which is simultaneously therapeutically effective and non-toxic, thus reducing side effects, after a single dose administration, throughout the gastrointestinal tract. The new formulations, employing hydroxypropylmethycellulose (HPMC K15M) (a cellulosic polymer, which, generally hydrates to form a gelatinous layer that is critical to prevent wetting and rapid drug release from the matrices), poly(methacylic acid-co-ethyl acrylate) 1:1 (Eudragit® L100-55: effective for site specific drug delivery in intestine), poly(ethylene oxide) (PEO) (7 × 106: a high molecular weight polymer, water-soluble, in micro-granular powder form), as the rate controlling polymers, were chosen to lead to a “soothing out” release pattern of these drugs, at 0 ≤ t ≤ 120 min. Moreover, the release of the two drugs from the ulvan-based tablets, was found to follow the desired profile, throughout the entire course of the dissolution experiments. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |